Spots Global Cancer Trial Database for Comparison Study of Transarterial Chemoembolization and Percutaneous Ethanol Injection for Multiple, Small HCCs
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Comparison Study of Transarterial Chemoembolization and Percutaneous Ethanol Injection for Multiple, Small HCCs
Official Title: A Multicenter, Randomized, Controlled Trial of the Effective Therapy for Multiple, Small Hepatocellular Carcinomas: Comparing Transarterial Chemoembolization With Percutaneous Ethanol Injection Therapy.
Study ID: NCT00357474
Conditions
Study Description
Brief Summary: The purpose of this study is to choose the preferred treatment modality for multiple, small hepatocellular carcinomas.
Detailed Description: To compare the below things between PEIT group and TACE group 1. Survival 1. 5 year overall survival rate 2. Disease free survival rate 2. Recurrence a. recurrence rate
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Seoul NUH, Seoul, Chongno-gu, Korea, Republic of
Contact Details
Name: J H Yoon, Professor
Affiliation: Seoul National University Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
